Tiludronate

Tiludronate

Clinical data
ATC code	M05BA05 (WHO)
Identifiers
IUPAC name {[(4-chlorophenyl)thio]methylene}bis(phosphonic acid)
CAS Number	89987-06-4
PubChem CID	60937
DrugBank	APRD01259
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C7H9ClO6P2S
Molar mass	318.609 g/mol

WikiDoc Resources for Tiludronate
Articles
Most recent articles on Tiludronate Most cited articles on Tiludronate Review articles on Tiludronate Articles on Tiludronate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tiludronate Images of Tiludronate Photos of Tiludronate Podcasts & MP3s on Tiludronate Videos on Tiludronate
Evidence Based Medicine
Cochrane Collaboration on Tiludronate Bandolier on Tiludronate TRIP on Tiludronate
Clinical Trials
Ongoing Trials on Tiludronate at Clinical Trials.gov Trial results on Tiludronate Clinical Trials on Tiludronate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tiludronate NICE Guidance on Tiludronate NHS PRODIGY Guidance FDA on Tiludronate CDC on Tiludronate
Books
Books on Tiludronate
News
Tiludronate in the news Be alerted to news on Tiludronate News trends on Tiludronate
Commentary
Blogs on Tiludronate
Definitions
Definitions of Tiludronate
Patient Resources / Community
Patient resources on Tiludronate Discussion groups on Tiludronate Patient Handouts on Tiludronate Directions to Hospitals Treating Tiludronate Risk calculators and risk factors for Tiludronate
Healthcare Provider Resources
Symptoms of Tiludronate Causes & Risk Factors for Tiludronate Diagnostic studies for Tiludronate Treatment of Tiludronate
Continuing Medical Education (CME)
CME Programs on Tiludronate
International
Tiludronate en Espanol Tiludronate en Francais
Business
Tiludronate in the Marketplace Patents on Tiludronate
Experimental / Informatics
List of terms related to Tiludronate

Tiludronic acid (INN) or Tiludronate (USAN), marketed as under the brand name Skelid®, is a bisphosphonate used to treat Paget's disease.

Administration

Tiludronic acid is administered orally. The recommended dose is a single 400-mg daily oral dose, taken with 6 to 8 ounces of plain water only, should be administered for a period of 3 months. Beverages other than plain water (including mineral water), food (see below), and some medications are likely to reduce the tiludronic acid's absorption.

External links

• Prescribing information for Skelid
• RxList page

Template:WikiDoc Sources